Forbion is a leading pan-European private markets firm focused on investing in high-quality life sciences companies across all stages of their development. Forbion provides capital and expertise to life sciences companies, enabling the development of new therapeutics that can impact the future of medicine.
Forbion is a dedicated life sciences venture capital firm with offices in The Netherlands and Germany. Forbion invests in life sciences companies that are active in the biopharmaceutical space, managing multiple fund strategies that cover all stages of biopharmaceutical drug development. The firm’s current team consists of more than 30 life sciences investment professionals that have built an impressive performance track record since the late nineties with investments in 95 companies across 8 funds. Forbion’s record of sourcing, building, and guiding life sciences companies has resulted in many breakthrough therapies and valuable exits. In addition to its financial return objectives, Forbion selects investments that will positively affect the health and well-being of patients. The firm is a signatory to the United Nations Principles for Responsible Investment.
Our Affiliates manage client assets across a diverse range of secular growth areas and are focused on creating value for their clients.